MoneyWorks4Me

The sales for the June 2026 quarter moved up 37.08% to Rs. 7562.60 millions as compared to Rs. 5516.90 millions during the corresponding quarter last year.Profit after tax for the quarter ended June 2026 reported a huge growth of 89.87% to Rs. 644.80  millions from Rs. 339.60 millions.OP of the company witnessed a marginal growth to 1117.30 millions from 695.20 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 7562.60 5516.90 37.08 7562.60 5516.90 37.08 23190.60 20792.10 11.54
Other Income 81.80 73.70 10.99 81.80 73.70 10.99 212.80 224.00 -5.00
PBIDT 1117.30 695.20 60.72 1117.30 695.20 60.72 2903.70 2245.70 29.30
Interest 36.40 42.30 -13.95 36.40 42.30 -13.95 145.50 147.60 -1.42
PBDT 1080.90 652.90 65.55 1080.90 652.90 65.55 2646.10 2098.10 26.12
Depreciation 213.20 197.50 7.95 213.20 197.50 7.95 801.70 719.20 11.47
PBT 867.70 455.40 90.54 867.70 455.40 90.54 1844.40 1378.90 33.76
TAX 222.90 115.80 92.49 222.90 115.80 92.49 467.20 368.90 26.65
Deferred Tax 5.60 10.90 -48.62 5.60 10.90 -48.62 61.70 121.50 -49.22
PAT 644.80 339.60 89.87 644.80 339.60 89.87 1377.20 1010.00 36.36
Equity 587.10 587.10 0.00 587.10 587.10 0.00 587.10 587.10 0.00
PBIDTM(%) 14.77 12.60 17.24 14.77 12.60 17.24 12.52 10.80 15.93

IOL Chem & Pharma Share Price

163.80 6.80 (4.33%)
20-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1901.00
Dr. Reddys Labs. 1181.35
Cipla 1437.65
Lupin 2203.10
Zydus Lifesciences 1108.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: